Drug choice to lowering risk contiguity with Morbus Hansen disease: A review article

Journal of Advanced Pharmacy Education and Research Pub Date : 2023-01-01 DOI:10.51847/cksxmt6vsy

N. Gofur, A. Gofur, H. Putri, Soesilaningtyas Soesilaningtyas, Annisa Nur Halimah, Dwiyanti Feriana, Elly Rusdiana, S. Wahjuni, Mia Laksmi Lita Rosa, Z. Yusof

引用次数: 0

查看原文本刊更多论文

降低Morbus Hansen病邻近风险的药物选择:综述文章

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Advanced Pharmacy Education and Research Health Professions-Pharmacy

CiteScore

1.00

自引率

0.00%

发文量

期刊介绍： Journal of Advanced Pharmacy Education & Research [JAPER] aims to explore the knowledge of pharmacy professionals and cater the need of research and development activities of both academia and Industries. Further, also aimed to bridge the gap between theoretical aspects of drug delivery concepts and practical clinical studies to make sure of the novel drug delivery system usefulness in health care system. The Journal having scope for researchers engaged in drug delivery field to utilize the scientific contents in a rightful way. Journal of Advanced Pharmacy Education & Research [JAPER], a broad-based journal was founded on two key tenets: To publish the most exciting researches with respect to the subjects of Pharmaceutical science. Secondly, to provide a rapid turn-around time possible for reviewing and publishing, and to disseminate the articles freely for research, teaching and reference purposes. Our objective is to inform authors of the decision on their manuscript as early as possible. Following acceptance, a paper will normally be published in the next available issue. Journal of Advanced Pharmacy Education & Research [JAPER], is using online manuscript submission, review and tracking system for quality and quick review processing. Review processing is performed by the editorial board members of JAPER, outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript.